JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
There are no items in your shopping cart
Featured Products
Axon 2547
CAS [1454585-06-8]
MF C23H19F3N8OMW 480.45
A potent, highly specific CK1δ/CK1ε inhibitor (IC50 values 44 nM and 260 nM for CK1δ, and CK1ε, respectively), that selectively inhibits breast cancer cell growth and survival. SR-3029 exhibits in vitro and in vivo PK properties suitable for use in xenograft studies of human cancers, including brain cancers.
KEYWORDS: SR 3029 | supplier | CK1δ/CK1ε inhibitor | CK1 inhibitor | SR3029 | CAS [1454585-06-8] | casein kinase | CK1 | Inhibitor | breast cancer | brain cancer | Wnt | catenin | signaling | HER2 | FLT3 | CK1-delta | CK1-epsilon
N-((6,7-difluoro-1H-benzo[d]imidazol-2-yl)methyl)-9-(3-fluorophenyl)-2-morpholino-9H-purin-6-amine
[1454585-06-8]
The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.
Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!
* Required Fields